Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme Review

International Collaboration

cited authors

  • Thethi, Tina K.; Pratley, Richard; Meier, Juris J.

authors

Publication Date

  • May 13, 2020

webpage

published in

category

keywords

  • GLP-1 analogue
  • Phase 3 study
  • cardiovascular disease
  • clinical trial
  • type 2 diabetes

start page

  • 1263

end page

  • 1277

volume

  • 22

issue

  • 8